NYSE - Delayed Quote USD
Biohaven Ltd. (BHVN)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 7:45 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
781,270.00
436,051.00
567,932.00
218,900.00
114,506.00
Operating Income
-781,270.00
-436,051.00
-567,932.00
-218,900.00
-114,506.00
Other Income Expense
30,912.00
26,500.00
-1,909.00
6,470.00
-4,162.00
Pretax Income
-750,358.00
-409,551.00
-569,841.00
-212,430.00
-118,668.00
Tax Provision
-3,753.00
-1,383.00
438.00
1,366.00
--
Net Income Common Stockholders
-746,605.00
-408,168.00
-570,279.00
-213,796.00
-118,668.00
Diluted NI Available to Com Stockholders
-746,605.00
-408,168.00
-570,279.00
-213,796.00
-118,668.00
Basic EPS
-9.30
-5.73
-12.75
-5.97
-3.31
Diluted EPS
-9.30
-5.73
-12.75
-5.97
-3.31
Basic Average Shares
79,173.79
71,200.53
44,741.32
35,822.51
35,822.51
Diluted Average Shares
79,173.79
71,200.53
44,741.32
35,822.51
35,822.51
Total Operating Income as Reported
-781,270.00
-436,051.00
-567,932.00
-218,900.00
-114,506.00
Total Expenses
781,270.00
436,051.00
567,932.00
218,900.00
114,506.00
Net Income from Continuing & Discontinued Operation
-746,605.00
-408,168.00
-570,279.00
-213,796.00
-118,668.00
Normalized Income
-746,605.00
-408,168.00
-570,279.00
-213,796.00
-118,668.00
EBIT
-781,270.00
-436,051.00
-567,932.00
-218,900.00
-114,506.00
EBITDA
-774,438.00
-429,139.00
-566,546.00
-217,507.00
-114,434.00
Reconciled Depreciation
6,832.00
6,912.00
1,386.00
1,393.00
72.00
Net Income from Continuing Operation Net Minority Interest
-746,605.00
-408,168.00
-570,279.00
-213,796.00
-118,668.00
Normalized EBITDA
-774,438.00
-429,139.00
-566,546.00
-217,507.00
-114,434.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
--
12/31/2020 - 9/23/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SRRK Scholar Rock Holding Corporation
30.55
+4.44%
EWTX Edgewise Therapeutics, Inc.
35.57
+0.17%
RVMD Revolution Medicines, Inc.
50.43
+0.86%
CYTK Cytokinetics, Incorporated
54.97
+0.81%
XENE Xenon Pharmaceuticals Inc.
44.86
+3.58%
CRNX Crinetics Pharmaceuticals, Inc.
59.09
+0.29%
BPMC Blueprint Medicines Corporation
86.00
0.00%
VRDN Viridian Therapeutics, Inc.
24.98
+2.97%
NUVL Nuvalent, Inc.
103.68
+1.49%
ARGX argenx SE
565.00
+3.89%